Question 6: Is there a role for Mannose-Binding Lectin measurement in Cystic Fibrosis management?

Related Experiment Video

Updated: Mar 30, 2026

Generation of Human Nasal Epithelial Cell Spheroids for Individualized Cystic Fibrosis Transmembrane Conductance Regulator Study
08:00

Generation of Human Nasal Epithelial Cell Spheroids for Individualized Cystic Fibrosis Transmembrane Conductance Regulator Study

Published on: April 11, 2018

11.2K

Bernadette Prentice1, Karen McKay2, Hiran Selvadurai2

  • 1Advanced Trainee Paediatric Respiratory and Sleep Medicine, The Sydney Children's Hospital Network; Department of Respiratory Medicine, The Children's Hospital at Westmead.

Paediatric Respiratory Reviews
|November 14, 2015
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Forskolin-induced Swelling in Intestinal Organoids: An In Vitro Assay for Assessing Drug Response in Cystic Fibrosis Patients
07:04

Forskolin-induced Swelling in Intestinal Organoids: An In Vitro Assay for Assessing Drug Response in Cystic Fibrosis Patients

Published on: February 11, 2017

20.3K
Standardized Measurement of Nasal Membrane Transepithelial Potential Difference NPD
09:47

Standardized Measurement of Nasal Membrane Transepithelial Potential Difference NPD

Published on: September 13, 2018

17.5K

Related Experiment Videos

Last Updated: Mar 30, 2026

Generation of Human Nasal Epithelial Cell Spheroids for Individualized Cystic Fibrosis Transmembrane Conductance Regulator Study
08:00

Generation of Human Nasal Epithelial Cell Spheroids for Individualized Cystic Fibrosis Transmembrane Conductance Regulator Study

Published on: April 11, 2018

11.2K
Forskolin-induced Swelling in Intestinal Organoids: An In Vitro Assay for Assessing Drug Response in Cystic Fibrosis Patients
07:04

Forskolin-induced Swelling in Intestinal Organoids: An In Vitro Assay for Assessing Drug Response in Cystic Fibrosis Patients

Published on: February 11, 2017

20.3K
Standardized Measurement of Nasal Membrane Transepithelial Potential Difference NPD
09:47

Standardized Measurement of Nasal Membrane Transepithelial Potential Difference NPD

Published on: September 13, 2018

17.5K

Related Concept Videos

Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

620
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
620
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

1.0K
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
1.0K

Articles linked to this work by shared authors, journal, and citation graph.

Making the Diagnosis of Primary Ciliary Dyskinesia in Australia.

Pediatric pulmonology·2026

Accuracy and reliability of personal home spirometers: a multicentre laboratory quality-control study in children and adults.

Respiratory medicine·2026

Growth and nutrition in early life for very preterm infants - Implications for neonatal lung health.

Paediatric respiratory reviews·2026

Anti-inflammatory and phosphorylation effects of CFTR modulator triple therapy in cystic fibrosis.

iScience·2026

The cystic fibrosis gut microbial dysbiosis index (CF-GMDI): a quantitative measure of gut microbial imbalance in children with cystic fibrosis.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2026

Sleep Disordered Breathing in Joubert Syndrome: Disease Spectrum in a Pediatric Cohort.

Pediatric neurology·2026

Paediatric palliative care in advanced cystic fibrosis: from prognosis-based to needs-based care across the disease trajectory.

Paediatric respiratory reviews·2026

Azithromycin for acute wheezing and bronchiolitis in children younger than six years: A systematic review and meta-analysis.

Paediatric respiratory reviews·2026

RSV in children: an evolving story from high burden to universal prevention.

Paediatric respiratory reviews·2026

Recent advances in pediatric pulmonology: Articles of interest to fellows. Azithromycin for preschool wheezing, combined maternal RSV immunization and infant nirsevimab, and oscillometric assessment of small-airway dysfunction.

Paediatric respiratory reviews·2026

Incidence of ventilator-associated pneumonia in neonatal intensive care units: a systematic review and meta-analysis.

Paediatric respiratory reviews·2026

Prevalence and type of respiratory issues following Tracheo-Oesophageal fistula repair in children and young people: A systematic review.

Paediatric respiratory reviews·2026

Glycemic biomarkers and cardiovascular disease in diabetes: a comparative analysis of population-based and clinical cohorts.

Frontiers in endocrinology·2026

Changes in CGM-Derived Glycemic Metrics and Triglyceride-Glucose Index During Ramadan in Adults With Type 2 Diabetes Using Real-Time Continuous Glucose Monitoring.

Journal of diabetes science and technology·2026

Berry Anthocyanins and Their Metabolites in Endothelial Dysfunction Associated with Diabetes and Cardiometabolic Risk.

Molecules (Basel, Switzerland)·2026

Comparative Metabolic Effects of Glibenclamide in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Life (Basel, Switzerland)·2026

Is It Possible to Bypass the Block in Cerebral Glucose Uptake Following TBI with Exogenous Lactate?

Metabolites·2026

Coniferaldehyde Reverses PGK1-3-Phosphoglycerate-L-Serine Metabolic Reprogramming in Hindlimb Ischemia.

Metabolites·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us